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Objectives This study sought to determine the time dependency of the endothelium-dependent
and -independent vascular responses after percutaneous coronary intervention (PCI) with drug-
eluting (DEB) or plain balloons, bare-metal (BMS), and drug-eluting (DES) stents, or controls.
Background Long-term endothelial dysfunction after DES implantation is associated with delayed
healing and late thrombosis.
Methods Domestic pigs underwent PCI using DEB or plain balloon, BMS, or DES. The dilated and
stented segments, and the proximal reference segments of stents and control arteries were ex-
planted at 5-h, 24-h, 1-week, and 1-month follow-up (FUP). Endothelin-induced vasoconstriction and
endothelium-dependent and -independent vasodilation of the arterial segments were determined in
vitro and were related to histological results.
Results DES- and BMS-treated arteries showed proneness to vasoconstriction 5 h post-PCI. The endothelium-
dependent vasodilation was profoundly (p  0.05) impaired early after PCI (9.8  3.7%, 13.4  9.2%,
.7  5.3%, and 7.6  4.7% using plain balloon, DEB, BMS, and DES, respectively), as compared with controls
49.6  9.5%), with slow recovery. In contrast to DES, the endothelium-related vasodilation of vessels treated
ith plain balloon, DEB, and BMS was increased at 1 month, suggesting enhanced endogenous nitric oxide
roduction of the neointima. The endothelium-independent (vascular smooth muscle–related) vasodilation
ecreased signiﬁcantly at 1 day, with slow normalization during FUP. All PCI-treated vessels exhibited imbal-
nce between vasoconstriction–vasodilation, which was more pronounced in DES- and BMS-treated vessels.
o correlation between histological parameters and vasomotor function was found, indicating complex inter-
ctions between the healing neoendothelium and smooth muscle post-PCI.
onclusions Coronary arteries treated with plain balloon, DEB, BMS, and DES showed time-dependent loss
f endothelial-dependent and -independent vasomotor function, with imbalanced contraction/dilation
apacity. (J Am Coll Cardiol Intv 2012;5:741–51) © 2012 by the American College of Cardiology Foundation
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742The loss of intact arterial wall structure due to atherosclerosis is
associated with impaired regulation of vascular tone, local
thrombus formation or inflammation, and vessel wall remod-
eling, such as aneurysms or adaptive or constrictive remodeling
(1–3). Despite immediate relief of the vessel obstruction by
percutaneous coronary intervention (PCI), the disrupted en-
dothelium and the mechanical tension of the media/adventitia
result in adverse clinical outcomes due to vessel thrombosis,
remodeling, and the development of neointimal hyperplasia
(2–5). Delayed endothelialization after drug-eluting stent (DES)
implantation is related to late vessel thrombosis, but paradoxically,
lesser degree of neointimal hyperplasia and restenosis (6–8) due to
endothelial flow-mediated focal heterogeneity of protein and gene
expression and biochemical pathways (2).
Recent in vivo and in vitro studies have shown that first-
generation DES implantation resulted in persistent endothelial
dysfunction with resistance to vasodilator nitrate (9–15). By
contrast, the endothelium-dependent coronary vasomotor
function remained relatively pre-
served after placement of the latest
generation of DES, such as
biolimus-eluting stents, and may
be related to better long-term
clinical outcome (12,16), although
this finding still remains to be con-
firmed. Comparative in vitro studies
performed in porcine coronary ar-
teries 1 month after bare-metal
stent (BMS) or DES implantation
consistently reported the loss of
endothelium-dependent vasodila-
tion, but heterogenous results re-
garding the vascular smooth mus-
cle cell–related vasomotor response
(10,17,18).
Interestingly, to date, no data
are available on the effect of drug-eluting balloons (DEB)
on coronary vasomotor reaction, even though the longitudinal
and vertical diffusion of the antiproliferative drug into the
endothelium and transmural layer, and the midterm persis-
tence of the drug in the arterial wall have been shown (19,20).
Furthermore, the time course of neoendothelial function and
healing arterial wall layer in relation to the developing neoin-
tima and restenosis has not been not investigated, despite the
fact that the timely vascular response to constrictors or endog-
enous and exogenous dilators (such as regular medicines in
patients with coronary artery diseases) strongly influences the
short- and long-term clinical outcomes (21).
Therefore, the aim of the present study was to determine
the time-dependent progress of the contractile and
endothelium-dependent and -independent vasodilation of
coronary arteries after PCI with DEB or plain balloon,
BMS, and DES in direct relation to the morphological
Abbreviations
and Acronyms
BMS  bare-metal stent(s)
DEB  drug-eluting
balloon(s)
DES  drug-eluting stent(s)
FUP  follow-up
LAD  left anterior
descending coronary artery
LCX  left circumflex
coronary artery
PCI  percutaneous
coronary intervention
QCA  quantitative coronary
angiography
RCA  right coronary arteryinjury in porcine coronary arteries. aMethods
Animal preparation. Domestic pigs (n  27) received a
oading dose of aspirin (100 mg) and clopidogrel (300 mg)
er os 1 day before PCI. After overnight fasting, anesthesia
as initiated with 12 mg/kg ketamine hydrochloride, 1
g/kg xylazine, and 0.04 mg/kg atropine and maintained
ith isoflurane and oxygen via a mask. After intratracheal
ntubation, the anesthesia was continued with a gas mixture
f 1.5 vol% to 2.5 vol% isoflurane, 1.8 vol% O2, and 0.5
ol% N2O. Blood pressure, O2 saturation, and electrocar-
diogram were monitored continuously; serum electrolytes
and blood gas (IL GEM Premier 3000, Bedford, Massa-
chusetts) were measured before and after intervention. The
experiments were conducted in the Institute of Diagnostic
Imaging and Radiation Oncology, University of Kaposvar,
Hungary. The investigations conform to the “Position of
the American Heart Association on Research Animal Use,”
adopted by the American Heart Association on November
11, 1984, and the relevant specific Hungarian laws were
followed.
Percutaneous coronary intervention. The right femoral ar-
ery was punctured under sterile conditions, and a 7-F
ntra-arterial sheath was placed. After a loading dose of
nfractionated heparin (200 IU/kg), a guiding catheter of
-F (Medtronic, Minneapolis, Minnesota) was introduced
ither into the left or right coronary artery ostium, and
oronary angiography was performed using a nonionic
ontrast agent. A guiding wire (Cordis, Miami Lake,
lorida) was introduced into the coronary arteries (left
nterior descending [LAD], left circumflex [LCX], or right
RCA] coronary arteries, first diagonal branch of the LAD,
nd obtuse marginal branch of the LCX) (Fig. 1). Stents
ere implanted randomly into the LAD and the LCX.
lain balloon, DEB, BMS, or DES were chosen randomly.
In accordance with the guidelines of pre-clinical stenting
xperiments (22), stents were implanted with an inflation
ime of 30 s and 10 to 12 atm to reach a stent/artery ratio of
.1:1. Due to the elasticity of the porcine coronary artery, a
.3:1 balloon/artery ratio was used for balloon overstretch
njury (19). Only 1 device was used for each artery. A
aximum of 3 stents were implanted in 1 animal, whereas
different balloons were used in 1 animal (randomly chosen
AD, LCX, or RCA for stents, and additionally, diagonal
ranches and obtuse marginalis of LCX for balloons)
Fig. 1). In addition, the balance of the affected arteries,
vailable devices, and follow-up (FUP) times were also
onsidered. The number of arteries with PCI was 5-5-5-9
or plain balloon, 13-6-5-5 for DEB, 5-7-5-6 for BMS, and
1-6-5-5 for DES at 5-h, 1 and 7  2 days, and 1-month
UP, respectively, in a total of 27 pigs (Fig. 1).
After control angiography, the guiding wire, the catheter,
nd the introducer sheath were removed, and the femoral
rteries were closed with FemoSeal closure device (St. Jude
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743Medical, St. Paul, Minnesota). The animals were then
allowed to recover from the anesthesia. Heart rate, oxygen
saturation, blood pressure, and electrocardiography were
monitored during the procedure.
Devices. The size and length of the plain balloon (test
alloon, not for human use), DEB (test balloons, 3-g
aclitaxel/mm2 balloon surface, not for human use), BMS
(test stent, not for human use), or DES (test stent, 3-g
paclitaxel/mm2 stent surface, not for human use) were 2.75
or 3.0 mm and 15 mm, respectively. All PCI devices were
constructed for pre-clinical experiments.
FUP examinations. FUP times were selected to correspond
Figure 1. Flow Chart of the Experiments
BMS  bare-metal stent(s); DEB  drug-eluting balloon(s); DES  drug-eluting
ﬂex coronary artery; PCI  percutaneous coronary intervention; QCA  quantito specific human findings. The 5-h and 1-day FUP revealor exclude PCI-induced vessel thrombosis, whereas 1-week
FUP is related to the active smooth muscle cell prolifera-
tion. Moreover, the 1-month FUP time in pigs matches
6-month FUP in humans (22–24). Thus, we have chosen
these FUP time points for measurement of the vascular
response to PCI accordingly.
During FUP, the animals were treated with a daily dose
of clopidogrel (75 mg) and aspirin (100 mg).
The animals underwent control coronary angiography
followed by euthanasia 5 h, 1 day, 7  2 days, and 1 month
(3 days) after index PCI with 10 ml of saturated potas-
sium chloride, and the hearts were explanted in toto (Fig. 1).
(s); FUP  follow-up; LAD  left anterior coronary artery; LCX  left circum-
coronary angiography; RCA  right coronary artery.stentThe coronary arteries were prepared, and the site of balloon
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744dilation, the stented segments, and the proximal segments
adjacent to stenting were cut and flushed with physiological
saline solution, then the vasomotor response of the cut (stent-
free) segments was measured. After completion of the in vitro
measurements, the balloon-dilated segments, the segments
with stents, and the proximal parts were fixed in 4% formalin.
The stented arteries were embedded in Technovit 9100
(Heraeus Kulzer GmbH, Wehrheim, Germany), whereas the
native coronary arteries were embedded in paraffin, cut into 4-
to 6-m-thick slices, and then stained with hematoxylin-eosin
nd MOVAT pentachrome stains (22,25).
Quantitative coronary angiography. Post-stent and FUP
uantitative coronary angiography (QCA) parameters were
easured by means of a computer-assisted quantitative
Figure 2. Schematic Illustration of the In Vitro Measurements of Vessel Va
(A) L-shaped metal pins in a myograph with a vessel (arrow). (B) Bath chamb
oxide). (D) Longitudinal section of the arteries and changes in response to the
the arteries in response to the applied solution and drugs (schematic illustratio
to the applied drugs. (G) Schematic illustration of the wall tension in response to thrteriographic edge-detection algorithm (ACOM.PC, Sie-
ens, Erlangen, Germany) (Online Methods 1).
Measurements of vasomotor responses. The dilated seg-
ent of the coronary arteries as well as the proximal
egments adjacent to the stents were isolated, and after the
emoval of fat and connective tissue, 4-mm-long ring
egments were cut and mounted in a temperature-controlled
5-ml tissue bath (37°C) containing a modified Krebs–
enseleit buffer solution (Fig. 2), as published previously
8) (Online Methods 2). Briefly, to measure the isometric
ircular wall tension of the vessels, each segment was sus-
ended between 2 L-shaped metal pins (0.4 mm in diameter)
n a myograph (8). After approximately 1 h, the vessels were
aximally contracted with endothelin-1 (30 nmol/l).
tor Reaction
h the L-shaped pins. (C) Applied (arrows) solution and drugs (NO  nitric
ed solution and drugs (schematic illustration). (E) Cross-sectional changes of
) Pathophysiological mechanism of the changes of the arteries in responsesomo
er wit
appli
n). (Fe applied drugs (blue line).
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745Maximum endothelium-dependent vasodilation was
achieved by a bolus application of substance P directly into
the organ bath with increasing concentration, up to a final
concentration of 1 nmol/l. Sensitivity of smooth muscle to
external nitric oxide (NO) was investigated by subsequent
addition of sodium nitroprusside (4 mmol/l). The vasocon-
striction, corresponding to media injury and/or endothelial
dysfunction in regulation of vascular tone, was expressed as
milliNewtons (mN). The endothelium-dependent and
-independent vasodilation (stiffness of vascular smooth
muscle after overstretch injury of PCI) were expressed in
percent change of steady-state level contraction, and in
mN/s/mN units, respectively.
Histopathology and histomorphometry. Each arterial seg-
ment (stented, balloon-dilated, and proximal to stents) was
cut into 3 parts (proximal, middle, and distal) and investigated
histopathologically and histomorphometrically. Stented seg-
ments were evaluated using recommendation of Schwartz et al.
(22) and Virmani et al. (6) (Online Methods 3).
Dilated segments or the segments proximal to stents were
analyzed similarly to the score system after stenting, adapted
for balloon injury only (19,25) (Online Methods 4). Endo-
thelial coverage was expressed as the percentage of the
lumen circumference covered by endothelium, measured by
computerized planimetry (ImageJ version 1.440, NIH, Be-
thesda, Maryland).
The following quantitative histomorphometric parame-
ters were measured: lumen, internal and external elastic
lamina area, and the maximal neointimal thickness. The
calculated histomorphometric parameters included the neo-
intima area (difference between internal elastic lamina and
lumen area), media area (difference between external and
internal elastic lamina area), and % area stenosis [(neointi-
mal area/internal elastic lamina area)  100].
Statistics. In the absence of normal values with standard
eviation or expected significant intraindividual change
nd, therefore, no possible sample size calculation regard-
ng the in vitro vasomotor function measurements, a
inimum number of 5 samples per group and 1 FUP
ime were attempted. No adjustments were made for
ultiple comparisons or for multiple observations within
nimals.
Continuous parameters were tested for normal distribu-
ion and expressed as mean  SD. Differences in variances
ere tested, and if the Levene test had a p value 0.05, a
onparametric test was used for comparison. In case of
qual variances, the analysis of variance was supplemented
ith 2-sided Student t test.
Correlation between vessel constriction and endothelium-
ependent and -independent vasodilation or between histolog-
cal and vasomotor parameters was evaluated using linear
egression analysis. A p value of 0.05 was considered signif-
cant. The statistical analyses were performed with SPSS foracintosh version 17 (SPSS Inc., Chicago, Illinois). (esults
FUP angiography. Coronary angiography at 5 h, 1 day and
7  2 days revealed no stenosis nor suspected thrombosis.
At the 1-month FUP, no angiographic abnormalities of the
dilated segments were seen. However, QCA documented
15  10% and 8  9% diameter stenosis of the stented
egments with BMS and DES, with a late lumen loss of
.78  0.32 mm and 0.24  0.21 mm, respectively. The
rterial segments proximal or distal to the stents showed no
ngiographic abnormalities.
Time dependency of the vasomotor reaction post-PCI.
Endothelin induced proneness to vasoconstriction in arter-
ies with DES or BMS (22.6  4.7 mN or 20.6  4.6 mN)
at the earliest time point (5 h) post-PCI, compared with
control (12.2  3.6 mN), or balloon-dilated arteries (p 
.05) (Figs. 3 and 4). Interestingly, 1-day post-PCI, the
asoconstrictive response seemed to be normalized in DES
nd BMS arteries. At 7 2 days post-PCI, the endothelin-
nduced vasoconstriction increased in drug-eluting device–
reated arteries (p  0.05 between controls and DEB/
ES), which was normalized at 1 month, as the vessel
epair was completed.
The endothelium-dependent vasodilation was signifi-
antly (p  0.05) decreased in all treated arteries 5 h
ost-PCI (49.6  9.5% vs. 9.8  3.7% or 13.4  9.2% or
5.7  5.3% or 7.6  4.7% in controls vs. plain balloon,
EB, BMS, or DES, respectively) compared with controls,
s an obvious sign of immediate endothelial layer injury
ost-PCI, with slow recovery (Fig. 4). At 1-month FUP, a
ypersensitivity of the neoendothelium-dependent vasodi-
ation to substance P was observed in PCI-treated arteries
but not DES-treated vessels) as compared with controls
p 0.05) (68.6 10.0% or 76.0 13.1% or 78.7 18.3%
in plain balloon, DEB, or BMS). By contrast, the
endothelium-dependent vasodilation remained significantly
depressed in DES-treated vessels (33.3  7.4%).
The endothelium-independent (muscular layer–related)
vasodilation was profoundly impaired 1 day post-PCI in
DEB/BMS/DES-treated arteries (0.062  0.045 mN/s/mN,
0.054  0.041 mN/s/mN, and 0.023  0.003 mN/s/mN,
respectively) compared with controls (0.142 0.047 mN/s/mN),
but to a lesser extent in plain balloon arteries, indicating less
media (muscular) damage with the plain balloon when com-
pared with DEB, BMS, or DES (Fig. 4). At 7-day FUP, the
dysfunction in endothelium-independent vasodilation still per-
sisted in DEB and DES-arteries.
Vasoconstriction–vasodilation balance of the epicardial
coronary vessels. A significant correlation was found be-
ween the vasoconstriction response and endothelium-
ependent vasodilation of the noninstrumented arteries
Fig. 5), indicating a physiological balance between contraction–
elaxation. However, after pooling the data for 1 device
independent from FUP time), no association could be
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746found between contraction and relaxation, suggesting an
imbalance in vasomotor function caused by PCI, with more
profound equilibrium disturbance if a stent was implanted.
No differences between the LAD, LCX, and RCA were
observed regarding the vasomotor responses.
Histology. Figure 6 and Online Figure 1 summarize the
ain histopathological and histomorphometric parameters
f the arteries at 5 h, 1 and 7  2 days, and 1 month
ost-PCI. The injury score was significantly (p  0.05)
ower in the balloon groups (0.92  0.31 and 0.90  0.45
or plain balloon and DEB, respectively) compared with the
tent groups (1.35  0.32 and 1.41  0.52 for BMS and
ES, respectively). The fibrin and inflammation score
ncreased in each group during the FUP (Online Fig. 1).
mplantation of the stents interrupted the endothelial con-
inuity in DES and BMS vessels 5 h post-PCI (p  0.05
etween BMS/DES vs. plain balloon/DEB). With the new
ndothelium partially covering the stent struts and the
nterstrut spaces in stents, the endothelialization was 98 
% in BMS- and 87  6% in DES-treated vessels at
-month FUP (Figs. 6 and 7).
A gradual increase in neointimal area was measured in all
roups during the FUP, with the highest degree of maximal
eointima areas and % area stenosis in BMS-treated vessels
2.07  0.72 mm2 and 46  14%) (p  0.05 between BMS
nd balloons/DES). The media area increased nonsignifi-
antly in DES-treated arteries at 1-month FUP (Figs. 6 and 7,
nline Fig. 1).
Comparison of histological ﬁndings and vasomotor function.
The proneness to vasoconstriction of the vessels at 5 h
post-PCI with a pseudonormalization at 1-day FUP failed
Figure 3. Vasomotor Reaction of the Treated Coronary Arteries After Coron
Vasomotor response of the vessels (A) 5 h post-intervention and (B) at 1 mon
2 different types of DEB and control. Vasoconstrictive response to endothelin
and endothelium-independent vasodilation to nitroprusside sodium (blue arroany histological correlate.Although endothelialization was significantly better in
balloon-dilated arteries early post-PCI as compared with
stented vessels, the endothelium-dependent vasodilation
was impaired similarly in all groups, suggesting an obvious
discrepancy between morphology and functionality of the
injured arteries. The endothelialization was almost complete
in all PCI-treated arteries at 1-month FUP, but the PCI-
treated arteries (except DES-treated vessels) exhibited a
higher responsiveness to endogenous NO production of the
new intimal layer when compared to controls.
The profound impairment of the endothelium-independent
vasodilation did not correlate with the injury score or medial
thickening at any time point.
Discussion
This is the first report on the time course of vasomotor
reactions of coronary arteries in response to PCI with different
coronary devices. The main findings of our study are:
1. DES-treated arteries showed increased vasoconstric-
tive response early post-DES implantation, together
with profound impairment of the endothelium-
dependent vasodilation and decrease in endothelium-
independent vasodilation. During the FUP, the
endothelium-dependent vasodilation response re-
mained impaired.
2. BMS implantation led to an injured vasomotor reac-
tion partially similar to DES, regarding the vasocon-
striction, endothelium-dependent, and -independent
tervention
t-PCI with DES, BMS implantation, and after dilation with plain balloon or
arrow), endothelium-dependent vasodilation to substance P (red arrow),
bbreviations as in Figure 1.ary In
th pos
(blackvasodilation with slow, but complete recovery.
Plain B  plain balloon; other abbreviations as in Figure 1.
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7473. Plain balloon use influenced neither the vasoconstric-
tive, nor the endothelium-independent vasodilation
response significantly, but similar to other PCI de-
vices, induced a prompt decrease in endothelium-
dependent vasodilation with slow normalization dur-
ing the 1-month FUP.
4. DEB-treated coronary arteries behaved generally sim-
ilarly to plain-balloon–treated vessels, regarding the
endothelium-dependent vasodilation, but similarly to
DES-treated arteries, and led to proneness to vaso-
constriction at 7 days and slow normalization of
endothelium-independent vasodilation.
The morphological (histological) parameters did not
correlate with the vasomotor reactions, suggesting highly
complex interactions between the neoendothelium or mus-
cular layers, and endogenous or exogenous vasoreactive
stimuli in coronary arteries post-PCI with an imbalance
between constriction/dilation responses.
PCI-induced vasomotor dysfunction of the coronary arteries.
Online Table 1 summarizes the published data on the
PCI-related vasomotor responses, emphasizing the impor-
tance of the impaired vasomotor reaction in relation to
adverse long-term events (9,14,15,26–28), such as in-stent
restenosis or major adverse cardiac events (1,29). Human
studies measured the vasomotor function mainly distal to
the stented arteries (9,12,14,16,17,26,27) or the flow-
mediated endothelium-dependent vasodilation induced ei-
ther by exercise (13,15,28) or atrial pacing (9,12), with the
consistent conclusion of loss of endothelium-dependent
vasodilation 6 to 9 months after DES placement. Similar to
our method, an organ-chamber model with modified myog-
raphy was used to measure the endothelium-dependent and
-independent vasodilation (1) with contractile reaction at
the proximal and distal parts of the stented arteries at
1-month FUP in a pre-clinical porcine model. These results
were comparable to humans regarding the endothelium-
dependent vasodilation, but heterogenous findings were
reported on impaired endothelium-independent vasodilation.
Both the in vivo and in vitro studies reported impaired
vasomotor function at FUP, when the endothelialization
should be almost complete. By contrast, we have measured
the time dependency of the vasomotor response, and re-
vealed important, albeit not completely explainable, mech-
anisms, such as profound impairment of the endothelium-
dependent dilation and proneness to constriction to
endothelin early after PCI, with a significantly different
response between stents and balloons. The strong and
permanent passive stretching of the endothelial and mus-
cular layers by stenting elicits hypersensitivity of the
adjacent arterial segments to endothelin, probably
through endothelin-related contraction due to interac-
tion with G protein– coupled receptors, or production ofFigure 4. Time-Dependent Vasoconstriction and Dilation Post-PCI
Time dependency of the (A) endothelin-induced vasoconstriction (*p 
0.05 between control/Plain B/DEB vs. BMS/DES; **p  0.05 between control
vs. DEB/DES), (B) endothelium-dependent vasodilation to substance P
(*p  0.05 between control vs. Plain B/DEB/BMS/DES; **p  0.05 between
control vs. Plain B/DEB/BMS; and †p  0.05 between DES vs. control/Plain
B/DEB/BMS), and (C) endothelium-independent vasodilation to nitroprus-
side sodium (*p  0.01 between control vs. DEB/BMS/DES; **p  0.05
between control vs. DEB/DES) of the vessels post-PCI with DES or BMS
implantation or dilation with plain balloon or DEB at 5 h, 1 and 7 days, and
1 month post-PCI. The gray rectangle represents the normal range (mean
value  1 SD). Each mean value and SD represent the measurements of
5-5-5-9 segments with plain balloon, 13-6-5-5 with DEB, 5-7-5-6 with BMS,
and 11-6-5-5 with DES at 5-h, 24-h, 1-week, and 1-month FUP, respectively.asymmetric dimethylarginine (30,31) increasing vascular
Figur
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748resistance. The application of DEB also sensitized the
arteries to endothelin-induced vasoconstriction 7 days
post-PCI, likely due to the accumulation of the drug
within the vessel wall.
Interesting is the time dependency of the endothelium-
dependent vasodilation without correlation with the re-
endothelialization progress. Similar to our findings, Li et al.
(10) and Pendyala et al. (5) showed an increased
endothelium-dependent dilation of the coronary arteries at
FUP, but without presenting comparative baseline data. By
contrast, other authors described a decrease of endothelium-
dependent vasodilation long after endothelial regrowth (17).
In our experiment, the increased endothelium-dependent
vasodilation at FUP can be assigned to the combination of
the original and newly developed endothelium, exceeding
the values of the native coronary arteries, indicating an
altered phenotype of the newly developed endothelium with
higher sensitivity to endogenous NO, with the exception of
DES-treated vessels.
The DEB exposes the arterial wall to the drug for a
limited time; usually, the drug is eliminated within days. By
Figure 5. Association Between Endothelin-Induced Vasoconstriction and E
to Maintain the Normal Vascular Tone
Pooled data of measurements of 1 device-type–related artery, independently f
dilation capacities of the normal (control) vessel (n  32). No correlation betw
(C) DEB (n  29), (D) BMS (n  23), and (E) DES (n  27). Abbreviations as incontrast, the mechanical characteristics of the plain balloonand DEB are similar. This might be the reason for the
similarity of some functional and histological findings be-
tween the 2 balloon types.
The obvious mismatch between vasoconstriction and
vasodilation found in all PCI-treated vessels suggests that
PCI of any type disturbs the physiological harmony between
the contractile and vasodilatory capacities to a much higher
extent if stents are implanted. Moreover, the localized
hypersensitivity or hyposensitivity of the newly developed
neointima to endogenous NO might result in turbulence in
the dilated and stented segment, further aggravating the
local shear stress.
Endothelium-independent vasodilation of PCI-treated coronary
vessels. The endothelium-independent vasodilation showed pro-
found impairment at 1 day, with slow recovery during the
FUP, suggesting a PCI-triggered time-dependent reor-
ganization of the muscular (medial and adventitial) layer
after arterial overstretch injury. Implantation of DES
impaired the smooth muscle cell–related vasodilation to a
larger extent than the other PCI device–treated arteries,
indicating a stronger dysfunction of the thickened media
lium-Dependent Vasodilation of the Vessels
e follow-up time. (A) Signiﬁcant linear correlation between the contraction/
ntraction and relaxation after implantation of (B) plain balloon (n  24),
e 1.ndothe
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een coand a pathological signaling pathway from the endothe-
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749lium to the medial smooth muscle cells, which may also
be influenced by the storage of the drug within the vessel
wall (1).
Association between vasomotor response and histological
changes. Stent implantation resulted in a higher injury
core than balloons, likely leading to a difference in vaso-
otor function between the stents and balloons. The
ifference is device-specific, as DEB use is associated with
hort-term overstretch with a short-term (days) high pacli-
axel level in the tissue (9,10), in contrast to the DES with
ts permanent arterial stretch and long-term slow- or mod-
rate release and penetration of drugs into the vessel wall.
he differences in vasomotor response of the various drug-
luting PCI devices can be attributed to the altered drug
elease kinetics, activation of P2 receptors, and other flow-
ediated mechanotransduction or cell-signaling processes
2,31). These local biological mechanisms in connection
ith the systemic inflammatory changes, proliferation, and
igration of the smooth muscle cells or local NO bioavail-
bility are thoroughly investigated in cell culture and in
re-clinical experiments (2,5,9,11,32), revealing device-
pecific profiles of the arteries.
Additionally, in our experiment, DES-treated arteries
howed susceptibility to vasoconstriction at 7-day (time of
mooth muscle cell activation) and incomplete recovery of
he endothelium-dependent vasodilation at 1-month FUP,
Figure 6. Time-Course of the Histopathological and Histomorphometric Cha
(A) Endothelialization and (B) neointimal area of the coronary arteries treated
measurements of 5-5-5-9 segments with plain balloon, 13-6-5-5 with DEB, 5-7-
respectively. Abbreviations as in Figure 1.hich might be due to the incomplete endothelialization m33). However, the time course of histopathological and
istomorphometric changes was not completely in accord
ith the time course of the vasomotor reactions.
Study limitations. We have investigated paclitaxel-coated
tents and balloons; a “limus” group–coated device was not
vailable for this experiment. However, the endothelium-
ependent vasodilation disturbances were reported to be
imilar in both drug-eluting groups.
We have only tested the proximal segment adjacent to the
tent, not the distal part, although it has been shown that
he distal part demonstrates inferior dilation capacity. How-
ver, such a comparison is already published (12) (Online
able 1) pointing out that the vasomotion of the nonstented
eference segments reflects both the local and the systemic
ndothelial functions, influenced by the local antiprolifera-
ive drug storage in case of DES.
All PCI devices were constructed for pre-clinical exper-
ments, not for human use. Using the test coronary devices
f different companies, we must take confidentiality into
onsideration. However, we have given the size and length
f the balloons and stents, and the paclitaxel concentration
f the drug-eluting balloons and stents, which design and
eatures are similar to the devices used in human PCI.
The coronary stents were implanted into the healthy
rteries of pigs, which is not representative of the
therosclerotic human coronaries. Being similar to hu-
Post-PCI
ither plain balloon, DEB, BMS, or DES. Each mean  SD value represents the
ith BMS, and 11-6-5-5 with DES at 5-h, 24-h, 1-week, and 1-month FUP,nges
with e
5-6 wans, the anatomy and pathophysiology of the coronary
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750arteries of pigs make this model attractive for basic
clinical translational research, and is well accepted as a
pre-clinical model of PCI.
Conclusions
Coronary arteries treated with plain balloon, DEB, BMS,
and DES showed time-dependent loss of endothelium-
dependent vasodilation with imbalanced increases in
endothelin-induced vasoconstriction and impaired endothelium-
independent vasodilation post-PCI with slow recovery,
which might influence the long-term outcome of PCI,
regarding re-stenosis, vessel remodeling, and thrombosis.
The novelty of our experiment is the serial observation, in
parallel with the 4 most-used PCI devices, and the
relationship between the functional and histological find-
Figure 7. Histology of Coronary Arteries 1 Month Post-PCI
(A) Lack of endothelialization 1 month post-PCI in a vessel treated with DES (a
1 month post-BMS implantation (MOVAT) with ﬁbrin deposition around the st
media and inﬂammatory reaction of the adventitia 1 month after overstretch i
cation). (D) Circular neointimal proliferation with thrombus adhesion 1 month
in Figure 1.ings. Furthermore, the presented in vitro experimentshave a potential to offer directions to the engineering of
new intracoronary devices.
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APPENDIX
For supplementary methods, figures, and tables, please see the online
version of this article.
